Sort
50,496 grants matching “lung cancer”
Personalized Task-Based Respiratory Motion Correction for Low-Dose PET/CT
$619,629Chi Liu · Yale University · R01 · FY2019 · CA
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$619,542Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
IDENTIFYING AND TARGETING MECHANISMS OF LUNG CANCER INITIATION
$619,500Sloan-Kettering Institute For Cancer Research · · FY2022 · Department of the Army
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
$619,471Beth A. Reboussin · Wake Forest University Health Sciences · U01 · FY2024 · CA
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis
$619,441Han Xiao · Rice University · R01 · FY2024 · CA
Reducing cardiac toxicity with deep learning and MRI-guided radiation therapy
$619,436Carri Kaye Glide-Hurst · University Of Wisconsin-Madison · R01 · FY2023 · HL
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers
$619,410Anant Madabhushi · Case Western Reserve University · R01 · FY2019 · CA
Role of IKK alpha in lung cancer development
$619,324Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
$619,304Balabhaskar Prabhakarpandian · Cfd Research Corporation · R44 · FY2013 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$619,255Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$619,253Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Probabilistic Multiscale Modeling of the Tumor Microenvironment
$619,118Wesley Tansey · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$619,098Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Impact of Medicare Part D on Cancer and Diabetes Disparities among Dual Enrollees
$619,081Alyce Sophia Adams · Kaiser Foundation Research Institute · R01 · FY2009 · AG
DNA Sequencing and Digital Gene Expression Core
$619,049Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
PROSPECTIVE STUDY OF ALASKA NATIVES &AMERICAN INDIANS
$619,019Black Hills Ctr/American Indian Health · R01 · FY2001 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$618,976Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Personalized Motion Management for truly 4D Lung Stereotactic Body Radiotherapy
$618,960Amit Sawant · University Of Maryland Baltimore · R01 · FY2018 · CA
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
$618,912Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Mechanisms of action and therapeutic targeting of the CARM1-NFIB axis in small cell lung cancer
$618,833Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
The role of DNAJB1-PKAc-β-catenin axis in fibrolamellar HCC
$618,809Nikolai A Timchenko · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · CA
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury
$618,741Eva Nozik Grayck · University Of Colorado Denver · R01 · FY2017 · HL
Clinical Pharmacogenetics
$618,723William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
$618,723William Douglas Figg · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
$618,713Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2023 · CA